Simulations Plus, Inc. (NASDAQ:SLP) Receives Average Recommendation of “Buy” from Brokerages

Simulations Plus, Inc. (NASDAQ:SLP) has earned an average recommendation of “Buy” from the seven ratings firms that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price objective among analysts that have covered the stock in the last year is $51.40.

SLP has been the subject of several research reports. StockNews.com lowered shares of Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a report on Wednesday, November 6th. Stephens initiated coverage on shares of Simulations Plus in a report on Friday. They issued an “overweight” rating and a $39.00 price target for the company. KeyCorp assumed coverage on shares of Simulations Plus in a report on Monday, July 29th. They issued an “overweight” rating and a $47.00 price target for the company. Finally, BTIG Research reduced their target price on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, October 24th.

Insider Buying and Selling at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $35.18, for a total transaction of $703,600.00. Following the sale, the director now directly owns 3,501,592 shares in the company, valued at approximately $123,186,006.56. The trade was a 0.57 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold 60,750 shares of company stock valued at $1,905,655 in the last ninety days. Company insiders own 20.90% of the company’s stock.

Institutional Trading of Simulations Plus

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Geode Capital Management LLC raised its position in shares of Simulations Plus by 4.4% during the 3rd quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company’s stock worth $14,367,000 after buying an additional 18,924 shares in the last quarter. Barclays PLC raised its holdings in shares of Simulations Plus by 390.6% in the 3rd quarter. Barclays PLC now owns 28,473 shares of the technology company’s stock worth $911,000 after purchasing an additional 22,669 shares in the last quarter. First National Bank of Omaha raised its holdings in shares of Simulations Plus by 56.1% in the 3rd quarter. First National Bank of Omaha now owns 9,704 shares of the technology company’s stock worth $311,000 after purchasing an additional 3,488 shares in the last quarter. State Street Corp raised its holdings in shares of Simulations Plus by 4.7% in the 3rd quarter. State Street Corp now owns 640,303 shares of the technology company’s stock worth $20,503,000 after purchasing an additional 28,953 shares in the last quarter. Finally, Petrus Trust Company LTA bought a new stake in shares of Simulations Plus in the 3rd quarter worth approximately $682,000. 78.08% of the stock is currently owned by institutional investors.

Simulations Plus Price Performance

Shares of SLP stock opened at $28.77 on Monday. Simulations Plus has a 1-year low of $27.22 and a 1-year high of $51.22. The firm has a fifty day moving average of $31.19 and a two-hundred day moving average of $38.88. The firm has a market cap of $577.41 million, a P/E ratio of 58.72 and a beta of 0.71.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.04 by $0.02. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The business had revenue of $18.70 million during the quarter, compared to analyst estimates of $19.73 million. During the same period in the previous year, the business posted $0.18 EPS. The company’s quarterly revenue was up 19.9% on a year-over-year basis. On average, sell-side analysts expect that Simulations Plus will post 1.12 EPS for the current year.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.